P1.01-110 Novel Regimens Versus Standard-of-Care in NSCLC: A Phase II, Randomized, Open-Label, Platform Trial Using a Master Protocol

D. Spigel,M. Garassino,B. Besse, A. Sacher,M. Barve,S. Cousin,M. Schenker, D. Rogan, S. Yadavilli, A. Acusta,O. Amit, A. Leighton-Swayze, M. Ballas, A. Hoos,M. Reck

JOURNAL OF THORACIC ONCOLOGY(2019)

引用 0|浏览15
暂无评分
关键词
ICOS-agonist,GSK3359609,advanced NSCLC
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要